SCHEMBL25112677

SCHEMBL25112677

c1ccc(-c2nc(-c3cccc(-c4cccc(-c5cc6ccc7cccc8c9cccc%10ccc%11cccc(c(c5)c6c78)c%11c%109)c4)c3)nc(-c3cccc4ccccc34)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
HPGD P15428 6/20 0.43
MAPT P10636 6/20 0.43
KDM4E B2RXH2 5/20 0.43
HSD17B10 Q99714 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
TSHR P16473 3/20 0.43
MAPK1 P28482 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
TP53 P04637 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
ATM Q13315 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CYP1A2 P05177 2/20 0.40
ERBB2 P04626 1/20 0.40
FYN P06241 1/20 0.40
MAOA P21397 1/20 0.40
ACHE P22303 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25112703 0.95 ALDH1A1 (0.41) ALDH1A1HPGDMAPTKDM4EHSD17B10
SCHEMBL25112574 0.92 CYP1A2 (0.46) ALDH1A1HPGDMAPTKDM4EHSD17B10
SCHEMBL25112590 0.91 ALDH1A1 (0.43) ALDH1A1HPGDMAPTKDM4EHSD17B10
SCHEMBL25112610 0.91 ALDH1A1 (0.43) ALDH1A1HPGDMAPTKDM4EHSD17B10
SCHEMBL25112679 0.90 CYP1A2 (0.45) ALDH1A1HPGDMAPTKDM4EHSD17B10
SCHEMBL25112680 0.90 CYP1A2 (0.38) ALDH1A1HPGDMAPTKDM4EHSD17B10
SCHEMBL25112630 0.90 CYP1A2 (0.40) ALDH1A1HPGDMAPTKDM4EHSD17B10
SCHEMBL25112700 0.90 CYP1A2 (0.40) ALDH1A1HPGDMAPTKDM4EHSD17B10
SCHEMBL25112676 0.89 CYP1A2 (0.44) ALDH1A1HPGDMAPTKDM4EHSD17B10
SCHEMBL25112706 0.88 CYP1A2 (0.39) ALDH1A1HPGDMAPTKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, PIEZO1, LEF1 ALDH1A1 192/4885HPGD 3868/4885MAPT 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.